Bayer, Huma team up on AI for lung cancer
Bayer and U.K.-based artificial intelligence (AI) software developer Huma ar...Read more on AuntMinnie.comRelated Reading:
BWXT and Bayer to focus on therapeutic radionuclides
Bayer launches Radimetrics upgrade
Bayer, Blackford team up on AI platform
Bayer to build Penn. distribution plan
Bayer, Healthy Women launch breast density campaign (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 30, 2021 Category: Radiology Source Type: news
TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation
ANDOVER, Mass., Sept. 29, 2021 -- (Healthcare Sales & Marketing Network) -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, hear... Devices, FDA TransMedics Group, OCS Liver System, portable extracorporeal (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 29, 2021 Category: Pharmaceuticals Source Type: news
New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO ® (rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related Events
RARITAN, NJ, September 27, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data from the Phase 3 UNIVERSE study showing treatment with XARELTO® (rivaroxaban) in an oral suspension formulation, compared to treatment with aspirin, was associated with numerically fewer blood clots and clinical events strongly associated with blood clots in pediatric patients (aged 2-8 years) who have undergone the Fontan procedure. [1] These findings, which were published this month in the Journal of the American Heart Association and included in a recent New Drug Application submitted to the U.S. F...
Source: Johnson and Johnson - September 27, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Lung Cancer, Non-Hodgkin Lymphoma Biggest Contributors to Life-Years Lost to Cancer in Transplant Patients Lung Cancer, Non-Hodgkin Lymphoma Biggest Contributors to Life-Years Lost to Cancer in Transplant Patients
Transplant recipients have a shortened lifespan after developing cancer, especially those who develop lung cancer and non-Hodgkin lymphoma, according to a new analysis.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 22, 2021 Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news
Electronic-Nose Technology Promising for Early Detection of Lung-Allograft Failure Electronic-Nose Technology Promising for Early Detection of Lung-Allograft Failure
Analysis of exhaled breath using an electronic nose (eNose) can aid in the early detection of chronic lung-allograft dysfunction in lung-transplant recipients.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 14, 2021 Category: Transplant Surgery Tags: Pulmonary Medicine News Source Type: news
COVID-19 Is Forcing Us to Talk About Rationing Health Care in the U.S. Again. Could We Have Avoided This?
On Sept. 7, the country’s leading COVID-19 doctor issued a dire warning about the growing number of pandemic cases in the country, and the shrinking number of ICU beds available to care for the sickest people. Speaking on CNN, Dr. Anthony Fauci, the chief White House medical advisor, said we are “perilously close in certain areas of the country of getting so close to having full occupancy that you’re going to be in a situation where you’re going to have to make some tough choices.”
Those tough choices, he admitted, include discussions about whether scarce resources should go to people who have...
Source: TIME: Health - September 10, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Median highlights AI lung cancer study
Median Technologies has released trial results showing that its artificial intelligenc...Read more on AuntMinnie.comRelated Reading:
Median posts 51% revenue increase for fiscal year 2020
Median taps new chief operating and commercial officer
Median signs research deal with UC San Diego
Median logs 51% growth in annual revenues
Median receives 15M euros in loan funding (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 9, 2021 Category: Radiology Source Type: news
Organ Transplant Activity Declined During 2020
The most affected organ transplants were kidney, followed by lung, liver, and heart (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 3, 2021 Category: Respiratory Medicine Tags: Cardiology, Gastroenterology, Nephrology, Pulmonology, Surgery, Conference News, Source Type: news
NIDCR's Fall 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page.
NIDCR's Fall 2021 E-Newsletter
In this issue:
NIDCR News
Funding Opportunities & Related Notices
NIH/HHS News
Subscribe to NICDR News
Science Advances
NIDCR News
5 Q&As About “Oral Health in America: Advances and Challenges”
NIDCR issued a brief Q&A regarding details of the forthcoming report Oral Health in America: Advances and Challenges, which will be published in Fall 2021. This comprehensive report will examine improvements in oral health over the past two decad...
Source: NIDCR Science News - September 1, 2021 Category: Dentistry Source Type: news
What are Some of the Complications of Short Bowel Syndrome?
Discussion
Necrotizing enterocolitis (NEC) is one of the most common gastrointestinal emergencies in neonates. Mortality rates are from 0-45% depending on infant weight and gestation with more premature and smaller infants having greater mortality. NEC usually occurs in premature infants but it also occurs in term infants. The etiology is unknown but is probably multifactorial with ischemia and/or reperfusion playing some role. There are ‘outbreaks’ of NEC but no causative organism has been identified. Regardless of the originating cause, inflammation of the intestine and release of inflammatory mediators causes variou...
Source: PediatricEducation.org - August 30, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) events in p...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
AI-based CAD software offers high sensitivity for lung nodules
Artificial intelligence (AI)-based computer-aided detection (CAD) software ca...Read more on AuntMinnie.comRelated Reading:
How accurate are models for predicting incidental lung nodules?
AI-based program helps follow up incidental lung nodules on CT
AI can predict malignancy for multiple pulmonary nodules
CT radiomics classifies small nodules found in CT lung screening
C-MIMI: AI peer review can spot missed lung cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 23, 2021 Category: Radiology Source Type: news
Optellum teams up with Johnson & Johnson
Artificial intelligence (AI) software developer Optellum is collaborating wit...Read more on AuntMinnie.comRelated Reading:
FDA clears Optellum's lung cancer diagnosis software
Optellum, Mirada present lung cancer study at RSNA 2017
Minnies 2017 semifinal candidates
Optellum unveils lung cancer analysis software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 18, 2021 Category: Radiology Source Type: news
Qure.ai secures FDA clearance for qER-Quant
Artificial intelligence (AI) software developer Qure.ai has garnered U.S. Foo...Read more on AuntMinnie.comRelated Reading:
Fujifilm's x-ray system connected with Qure.ai algorithm
AstraZeneca, Qure.ai partner for lung cancer diagnosis
Qure.ai adds Bresenham to advisory team
Qure.AI gets FDA clearance for head CT AI software
Nanox teams up with Qure.ai (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 17, 2021 Category: Radiology Source Type: news
WVU Medicine rolls out unique mobile lung cancer screening unit
WVU Medicine is employing a unique high-tech mobile unit to bring lung cancer screenings across West Virginia.
LUCAS (Lung Cancer Screening) includes an artificial-intelligence CT unit that provides lung cancer screenings without having to have an outside power source. It’s enclosed in a special 18-wheeler truck with a Canon Medical Systems USA Inc. CT unit plus other technology and personnel from the WV U Cancer Institute, which is part of WVU Medicine’s campus in Morgantown, West Virginia.
Lung… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2021 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news
